Cargando…
Effect of Naloxegol on Opioid-Induced Esophageal Motility Disorder
Opioid effects on lower gastrointestinal motility are well documented, and increasing attention is being paid to their effect on esophageal motility. Naloxegol is a µ-opioid receptor antagonist that is used for opioid-induced constipation, but its impact on esophageal motility has not been well docu...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8791044/ https://www.ncbi.nlm.nih.gov/pubmed/35097149 http://dx.doi.org/10.14309/crj.0000000000000723 |
_version_ | 1784640135322664960 |
---|---|
author | Ulteig, Crista Ciezki, Kristin Jacobson, Megan Singh, Maharaj Sharma, Tarun |
author_facet | Ulteig, Crista Ciezki, Kristin Jacobson, Megan Singh, Maharaj Sharma, Tarun |
author_sort | Ulteig, Crista |
collection | PubMed |
description | Opioid effects on lower gastrointestinal motility are well documented, and increasing attention is being paid to their effect on esophageal motility. Naloxegol is a µ-opioid receptor antagonist that is used for opioid-induced constipation, but its impact on esophageal motility has not been well documented. We report a case series of 3 patients with coexisting esophageal dysmotility and constipation on chronic opioids that improved both symptoms after starting naloxegol. Based on these observational studies, we propose that formal studies be conducted to assess the effect of naloxegol on opioid-induced esophageal dysmotility. |
format | Online Article Text |
id | pubmed-8791044 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Wolters Kluwer |
record_format | MEDLINE/PubMed |
spelling | pubmed-87910442022-01-27 Effect of Naloxegol on Opioid-Induced Esophageal Motility Disorder Ulteig, Crista Ciezki, Kristin Jacobson, Megan Singh, Maharaj Sharma, Tarun ACG Case Rep J Case Report Opioid effects on lower gastrointestinal motility are well documented, and increasing attention is being paid to their effect on esophageal motility. Naloxegol is a µ-opioid receptor antagonist that is used for opioid-induced constipation, but its impact on esophageal motility has not been well documented. We report a case series of 3 patients with coexisting esophageal dysmotility and constipation on chronic opioids that improved both symptoms after starting naloxegol. Based on these observational studies, we propose that formal studies be conducted to assess the effect of naloxegol on opioid-induced esophageal dysmotility. Wolters Kluwer 2022-01-25 /pmc/articles/PMC8791044/ /pubmed/35097149 http://dx.doi.org/10.14309/crj.0000000000000723 Text en © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of The American College of Gastroenterology. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) , where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. |
spellingShingle | Case Report Ulteig, Crista Ciezki, Kristin Jacobson, Megan Singh, Maharaj Sharma, Tarun Effect of Naloxegol on Opioid-Induced Esophageal Motility Disorder |
title | Effect of Naloxegol on Opioid-Induced Esophageal Motility Disorder |
title_full | Effect of Naloxegol on Opioid-Induced Esophageal Motility Disorder |
title_fullStr | Effect of Naloxegol on Opioid-Induced Esophageal Motility Disorder |
title_full_unstemmed | Effect of Naloxegol on Opioid-Induced Esophageal Motility Disorder |
title_short | Effect of Naloxegol on Opioid-Induced Esophageal Motility Disorder |
title_sort | effect of naloxegol on opioid-induced esophageal motility disorder |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8791044/ https://www.ncbi.nlm.nih.gov/pubmed/35097149 http://dx.doi.org/10.14309/crj.0000000000000723 |
work_keys_str_mv | AT ulteigcrista effectofnaloxegolonopioidinducedesophagealmotilitydisorder AT ciezkikristin effectofnaloxegolonopioidinducedesophagealmotilitydisorder AT jacobsonmegan effectofnaloxegolonopioidinducedesophagealmotilitydisorder AT singhmaharaj effectofnaloxegolonopioidinducedesophagealmotilitydisorder AT sharmatarun effectofnaloxegolonopioidinducedesophagealmotilitydisorder |